Evidence map›Paper›PMID 38203832›Full record

ArticleInternational journal of molecular sciences2024

Characterization of the Effect of

Rocío Nieto-Meneses, Rafael Castillo, Alicia Hernández-Campos, Benjamín Nogueda-Torres, Edgar Oliver López-Villegas, Adriana Moreno-Rodríguez, Félix Matadamas-Martínez, Lilián Yépez-Mulia

Open access · goldAbstract read
In one paragraph

Article in International journal of molecular sciences, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
1.1field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 2 citations in OpenAlex.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 1 country.

Rocío Nieto-MenesesDepartamento de Parasitología, ENCB-Instituto Politécnico Nacional, Mexico City 11340, Mexico.
Rafael CastilloDepartamento de Farmacia, Facultad de Química, Universidad Nacional Autónoma de México, Mexico City 04510, Mexico.ORCID 0000-0003-4466-2340
Alicia Hernández-CamposDepartamento de Farmacia, Facultad de Química, Universidad Nacional Autónoma de México, Mexico City 04510, Mexico.ORCID 0000-0003-4609-6581
Benjamín Nogueda-TorresDepartamento de Parasitología, ENCB-Instituto Politécnico Nacional, Mexico City 11340, Mexico.ORCID 0000-0001-9564-7066
Edgar Oliver López-VillegasCentral de Microscopia, ENCB-Instituto Politécnico Nacional, Mexico City 11340, Mexico.ORCID 0000-0002-9995-2145
Adriana Moreno-RodríguezFacultad de Ciencias Químicas, Universidad Autónoma Benito Juárez de Oaxaca, Oaxaca 68120, Mexico.ORCID 0000-0003-4100-8255
Félix Matadamas-MartínezUnidad de Investigación Médica en Enfermedades Infecciosas y Parasitarias-UMAE Hospital de Pediatría, Centro Médico Nacional Siglo XXI, Instituto Mexicano del Seguro Social, Mexico City 06720, Mexico.
Lilián Yépez-MuliaUnidad de Investigación Médica en Enfermedades Infecciosas y Parasitarias-UMAE Hospital de Pediatría, Centro Médico Nacional Siglo XXI, Instituto Mexicano del Seguro Social, Mexico City 06720, Mexico.ORCID 0000-0001-8675-5671
Mexican Social Security Institute · MXInstituto Politécnico Nacional · MXUniversidad Nacional Autónoma de México · MXBenito Juárez Autonomous University of Oaxaca · MX

Funding

Mexican Social Security Institute FIS/IMSS/PROT/G12/1130
6 · The paper itself

Abstract

Chemotherapy currently available for leishmaniasis treatment has many adverse side effects and drug resistance. Therefore, the identification of new targets and the development of new drugs are urgently needed. Previously, we reported the synthesis of a

Indexed as

Leishmania mexicanaLeishmaniasis, CutaneousAminesApoptosisArginaseBenzimidazolesHumansAminesArginaseBenzimidazolesbenzimidazole derivativein vivo activityleishmanicidal activityROS productionultrastructural studies

Identifiers

PMID38203832
PMCPMC10779428
OpenAlexW4390601494

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.